Overview

A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands

Status:
Completed

Trial end date:
2008-09-01

Target enrollment:

Participant gender:

Summary

The medications being used in this study are individually approved by the Food and Drug Administration (FDA). The medication under investigation is a combination of the two medications in one inhaler. The purpose of the study is to determine how the medication affects the amount, if any, of cortisol produced by the adrenal glands.

Phase:

Phase 1

Details

Lead Sponsor:

SkyePharma AG

Collaborator:

Abbott

Treatments:

Fluticasone
Formoterol Fumarate
Prednisone